VA Connecticut Healthcare System, West Haven, CT, United States.
Yale School of Medicine, New Haven, CT, United States.
JMIR Res Protoc. 2024 Aug 28;13:e59918. doi: 10.2196/59918.
Intimate partner violence (IPV) is a significant public health problem with far-reaching consequences. The health care system plays an integral role in the detection of and response to IPV. Historically, the majority of IPV screening initiatives have targeted women of reproductive age, with little known about men's IPV screening experiences or the impact of screening on men's health care. The Veterans Health Administration (VHA) has called for an expansion of IPV screening, providing a unique opportunity for a large-scale evaluation of IPV screening and response across all patient populations.
In this protocol paper, we describe the recently funded Partnered Evaluation of Relationship Health Innovations and Services through Mixed Methods (PRISM) initiative, aiming to evaluate the implementation and impact of the VHA's IPV screening and response expansion, with a particular focus on identifying potential gender differences.
The PRISM Initiative is guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) and Consolidated Framework for Implementation Research (CFIR 2.0) frameworks. We will use mixed methods data from 139 VHA facilities to evaluate the IPV screening expansion, including electronic health record data and qualitative interviews with patients, clinicians, and national IPV program leadership. Quantitative data will be analyzed using a longitudinal observational design with repeated measurement periods at baseline (T0), year 1 (T1), and year 2 (T2). Qualitative interviews will focus on identifying multilevel factors, including potential implementation barriers and facilitators critical to IPV screening and response expansion, and examining the impact of screening on patients and clinicians.
The PRISM initiative was funded in October 2023. We have developed the qualitative interview guides, obtained institutional review board approval, extracted quantitative data for baseline analyses, and began recruitment for qualitative interviews. Reports of progress and results will be made available to evaluation partners and funders through quarterly and end-of-year reports. All data collection and analyses across time points are expected to be completed in June 2026.
Findings from this mixed methods evaluation will provide a comprehensive understanding of IPV screening expansion at the VHA, including the implementation and impact of screening and the scope of IPV detected in the VHA patient population. Moreover, data generated by this initiative have critical policy and clinical practice implications in a national health care system.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/59918.
亲密伴侣暴力（IPV）是一个具有深远影响的重大公共卫生问题。医疗保健系统在检测和应对 IPV 方面发挥着重要作用。历史上，大多数 IPV 筛查计划都针对生育年龄的女性，而对于男性的 IPV 筛查体验或筛查对男性健康护理的影响知之甚少。退伍军人健康管理局（VHA）呼吁扩大 IPV 筛查范围，这为在所有患者群体中大规模评估 IPV 筛查和应对措施提供了独特的机会。
在本研究方案中，我们描述了最近资助的通过混合方法评估关系健康创新和服务的伙伴关系（PRISM）计划，旨在评估 VHA 的 IPV 筛查和扩大范围的实施和影响，特别关注潜在的性别差异。
PRISM 计划由扩展评估、有效性、采用、实施和维护（RE-AIM）以及综合实施研究框架（CFIR 2.0）框架指导。我们将使用来自 139 个 VHA 设施的混合方法数据来评估 IPV 筛查的扩大范围，包括电子健康记录数据和对患者、临床医生和国家 IPV 项目领导层的定性访谈。定量数据将使用纵向观察设计进行分析，在基线（T0）、第 1 年（T1）和第 2 年（T2）进行重复测量。定性访谈将重点确定多层次因素，包括对 IPV 筛查和应对扩大至关重要的潜在实施障碍和促进因素，并检查筛查对患者和临床医生的影响。
PRISM 计划于 2023 年 10 月获得资助。我们已经制定了定性访谈指南，获得了机构审查委员会的批准，提取了基线分析的定量数据，并开始招募定性访谈。将通过季度和年终报告向评估伙伴和资助者报告进展和结果。预计所有时间点的数据收集和分析都将在 2026 年 6 月完成。
这项混合方法评估的结果将全面了解 VHA 中的 IPV 筛查扩大范围，包括筛查的实施和影响以及在 VHA 患者群体中检测到的 IPV 范围。此外，该计划产生的数据在国家卫生保健系统中具有重要的政策和临床实践意义。
国际注册报告标识符（IRRID）：PRR1-10.2196/59918。
